Cervical dysplasia screening

Revision as of 19:17, 17 August 2015 by Jyostna Chouturi (talk | contribs)
Jump to navigation Jump to search

Cervical dysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cervical Dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cervical dysplasia screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cervical dysplasia screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cervical dysplasia screening

CDC on Cervical dysplasia screening

Cervical dysplasia screening in the news

Blogs on Cervical dysplasia screening

Directions to Hospitals Treating Cervical dysplasia

Risk calculators and risk factors for Cervical dysplasia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Pap Smear

Cervical dysplasia that is seen on a Pap smear is called squamous intraepithelial lesion (SIL). These changes may be graded as:

  • Low-grade (LSIL)
  • High-grade (HSIL)
  • Possibly cancerous (malignant)

If a Pap smear shows abnormal cells or cervical dysplasia, further testing or monitoring will be recommended:

  • Follow-up Pap smears may be recommended for mild cases
  • Colposcopy-directed biopsy can confirm the condition
  • Cone biopsy may be done after colposcopy

Dysplasia that is seen on a biopsy of the cervix is called cervical intraepithelial neoplasia (CIN). It is grouped into three categories:

  • CIN I -- mild dysplasia
  • CIN II -- moderate to marked dysplasia
  • CIN III -- severe dysplasia to carcinoma in situ

Some strains of human papillomavirus (HPV) are known to cause cervical cancer. An HPV DNA test can identify the high-risk types of HPV linked to such cancer. This may be done:

  • As a screening test for women over age 30
  • For women of any age who have a slightly abnormal Pap test result

References


Template:WikiDoc Sources